1146 feeds
357 categories
12876 articles (<24 hours)
47 registered users

Use the Mobile version

Follow our Twitter feed

View our Linkpartners


Register | Retrieve


Valid HTML 4.01 Transitional

RSS FeedsAlexion and Halozyme Enter License Agreement for ENHANZE Technology
(World News USA)


7 december 2017 13:39:35

Alexion and Halozyme Enter License Agreement for ENHANZE Technology
(World News USA)

NEW HAVEN, Conn. & SAN DIEGO--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced today a collaboration and license agreement that enables Alexion to use Halozyme`s ENHANZE drug-delivery technology in the development of subcutaneous formulations for their portfolio of products. The agreement provides Alexion with the opportunity for exclusive development of up to four targets, including a next generation subcutaneous formulation of ALXN1210 (ALXN1210 SC), the company`s investigational long-acting C5 complement inhibitor, to potentially further extend the dosing interval of ALXN1210 SC to once every two weeks or once per month....
3 viewsCategory: General > North America > USA
Sherpa`s Sponsors AmCham Shanghai`s 16th Annual Appreciation Dinner
(World News USA)
Asked and Answered: Dec. 7
(World News USA)
blog comments powered by Disqus

Copyright © 2008 - 2017 Indigonet Services B.V.. Contact: Tim Hulsen
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn
Indigonet Services BV is not responsible for any incorrect or outdated information on this site.
If, however, you would like to see an article removed, you can send us an e-mail quoting the article number.